Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company’s breast cancer recurrence assay, MammaPrint, in the Middle East.